Saturday, September 5, 2026

BanColombia S.A. And 6 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team

December 14, 2020

BanColombia S.A. And 6 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Western Alliance Bancorporation

15.8% sales growth and 14.35% return on equity

Western Alliance Bancorporation sales growth this year is anticipated to be 11.2% and 4.8% for next year.

Year-on-year quarterly revenue growth grew by 3.1%, now sitting on 1.03B for the twelve trailing months.

Western Alliance Bancorporation's sales growth for the next quarter is 15.8%. The company's growth estimates for the ongoing quarter and the next is 4.8% and 48.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.35%.

Western Alliance Bancorporation's Stock Top and Bottom Yearly Value

Western Alliance Bancorporation's stock is valued at $58.13 at 16:57 EST, below its 52-week high of $59.38 and way higher than its 52-week low of $20.90.

Western Alliance Bancorporation's Moving Average

Western Alliance Bancorporation's worth is way higher than its 50-day moving average of $50.12 and way above its 200-day moving average of $40.04.

2. Horizon Therapeutics Public Limited Company

82.2% sales growth and 29.59% return on equity

Horizon Therapeutics Public Limited Company sales growth this year is expected to be 64.1% and 38.3% for next year.

Year-on-year quarterly revenue growth grew by 89.7%, now sitting on 1.82B for the twelve trailing months.

Horizon Therapeutics Public Limited Company's sales growth for the next quarter is 82.2%. The company's growth estimates for the ongoing quarter and the next is 82.1% and 150%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 29.59%.

Horizon Therapeutics Public Limited Company's Stock Top and Bottom Yearly Value

Horizon Therapeutics Public Limited Company's stock is valued at $75.57 at 16:57 EST, way below its 52-week high of $86.67 and way higher than its 52-week low of $23.81.

Horizon Therapeutics Public Limited Company's Moving Average

Horizon Therapeutics Public Limited Company's value is higher than its 50-day moving average of $72.87 and way above its 200-day moving average of $67.78.

3. SPS Commerce, Inc.

10.8% sales growth and 11.16% return on equity

SPS Commerce, Inc. sales growth this year is anticipated to be 11% and 9.6% for next year.

Year-on-year quarterly revenue growth grew by 12.2%, now sitting on 302.06M for the twelve trailing months.

SPS Commerce, Inc.'s sales growth for the next quarter is 10.8%. The company's growth estimates for the present quarter and the next is a negative 2.9% and negative -2.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.16%.

SPS Commerce, Inc.'s Stock Top and Bottom Yearly Value

SPS Commerce, Inc.'s stock is valued at $98.75 at 16:57 EST, below its 52-week high of $104.99 and way above its 52-week low of $31.28.

SPS Commerce, Inc.'s Moving Average

SPS Commerce, Inc.'s value is above its 50-day moving average of $93.84 and way higher than its 200-day moving average of $80.75.

4. Capital City Bank Group

28.1% sales growth and 12.48% return on equity

Capital City Bank Group sales growth this year is expected to be 36.3% and a negative 2.3% for next year.

Year-on-year quarterly revenue growth grew by 49.5%, now sitting on 188.94M for the twelve trailing months.

Capital City Bank Group's sales growth for the next quarter is 28.1%. The company's growth estimates for the present quarter and the next is a negative 2% and 76%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.48%.

Capital City Bank Group's Stock Top and Bottom Yearly Value

Capital City Bank Group's stock is valued at $25.55 at 16:57 EST, way below its 52-week high of $30.95 and way higher than its 52-week low of $15.61.

Capital City Bank Group's Moving Average

Capital City Bank Group's worth is way above its 50-day moving average of $23.16 and way above its 200-day moving average of $20.82.

5. BanColombia S.A.

42.3% sales growth and 3.58% return on equity

BanColombia S.A. sales growth this year is anticipated to be 14.7% and 2% for next year.

Year-on-year quarterly revenue growth declined by 0%, now sitting on N/A for the twelve trailing months.

BanColombia S.A.'s sales growth for the next quarter is 42.3%. The company's growth estimates for the ongoing quarter and the next is a negative 68.4% and 2.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.58%.

BanColombia S.A.'s Stock Top and Bottom Yearly Value

BanColombia S.A.'s stock is valued at $37.34 at 16:57 EST, way under its 52-week high of $56.10 and way above its 52-week low of $16.27.

BanColombia S.A.'s Moving Average

BanColombia S.A.'s value is way higher than its 50-day moving average of $29.55 and way higher than its 200-day moving average of $27.85.

6. Provident Bancorp, Inc.

14.8% sales growth and 5.45% return on equity

Provident Bancorp, Inc. sales growth this year is expected to be 23% and 4.4% for next year.

Year-on-year quarterly revenue growth grew by 25.6%, now sitting on 47.86M for the twelve trailing months.

Provident Bancorp, Inc.'s sales growth for the next quarter is 14.8%. The company's growth estimates for the current quarter and the next is 35.7% and 57.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.45%.

Provident Bancorp, Inc.'s Stock Top and Bottom Yearly Value

Provident Bancorp, Inc.'s stock is valued at $11.48 at 16:57 EST, way under its 52-week high of $12.92 and way higher than its 52-week low of $7.21.

Provident Bancorp, Inc.'s Moving Average

Provident Bancorp, Inc.'s worth is way higher than its 50-day moving average of $9.44 and way higher than its 200-day moving average of $8.43.

7. Spirit of Texas Bancshares, Inc.

13.8% sales growth and 7.72% return on equity

Spirit of Texas Bancshares, Inc. sales growth this year is anticipated to be 28.1% and 0.9% for next year.

Year-on-year quarterly revenue growth grew by 26.7%, now sitting on 105.82M for the twelve trailing months.

Spirit of Texas Bancshares, Inc.'s sales growth for the next quarter is 13.8%. The company's growth estimates for the present quarter and the next is 70.8% and 54.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.72%.

Spirit of Texas Bancshares, Inc.'s Stock Top and Bottom Yearly Value

Spirit of Texas Bancshares, Inc.'s stock is valued at $16.70 at 16:57 EST, way under its 52-week high of $23.48 and way higher than its 52-week low of $8.96.

Spirit of Texas Bancshares, Inc.'s Moving Average

Spirit of Texas Bancshares, Inc.'s value is way higher than its 50-day moving average of $15.03 and way higher than its 200-day moving average of $12.87.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com